HAPI Hour Seminar: What Criteria Do Regulatory Agencies Use to Approve New Medical Interventions by John Powers, MD
John H. Powers MD will speak about how the FDA does not follow their own rules for some approvals.
Dr. Powers is a Professor of Clinical Medicine at the George Washington University School of Medicine. Prior to his current position, Dr. Powers was the lead medical officer for Antimicrobial Drug Development and Resistance Initiatives at the US Food and Drug Administration. While there, he was responsible for issues related to clinical trials and policy in antimicrobial research. Prior to joining the FDA, Dr. Powers was an assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine. He is still on the faculty there as an Assistant Clinical Professor of Medicine and actively sees patients in the clinic.
Dr. Powers is also a fellow at the American College of Physicians and the Infectious Diseases Society of America and has contributed to a variety of working groups and committees within the IDSA, the Veterans Administration, and the World Health Organization. He has also been an investigator on more than 50 clinical trials. He has particular expertise in the design, conduct, and analysis of clinical trials, and has published on various aspects of clinical trial design.
Wednesday, September 18 at 4:00pm to 6:00pm
Building D, Warwick Evans Conference Room
No recent activity